besponsa - inotuzumab ozogamicin injection, powder, lyophilized, for solution
(Inotuzumab Ozogamicin)Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.
Usage: Besponsa treats relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL) in adults and pediatric patients aged 1 year and older.